Humacyte, Inc.
HUMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $275,465 | $324,864 | $224,860 | $598,319 |
| - Cash | $19,488 | $38,032 | $62,847 | $44,937 |
| + Debt | $29,825 | $83,964 | $15,850 | $16,537 |
| Enterprise Value | $285,802 | $370,796 | $177,863 | $569,919 |
| Revenue | $753 | $301 | $517 | $7,228 |
| % Growth | 150.2% | -41.8% | -92.8% | – |
| Gross Profit | $493 | -$1,772 | -$1,462 | $3,614 |
| % Margin | 65.5% | -588.7% | -282.8% | 50% |
| EBITDA | -$13,033 | -$33,253 | $43,971 | -$16,624 |
| % Margin | -1,730.8% | -11,047.5% | 8,505% | -230% |
| Net Income | -$17,510 | -$37,658 | $39,139 | -$20,940 |
| % Margin | -2,325.4% | -12,511% | 7,570.4% | -289.7% |
| EPS Diluted | -0.11 | -0.24 | 0.28 | -0.16 |
| % Growth | 54.2% | -185.7% | 275% | – |
| Operating Cash Flow | -$23,904 | -$26,413 | -$28,601 | -$26,577 |
| Capital Expenditures | -$49 | -$568 | -$228 | -$63 |
| Free Cash Flow | -$23,953 | -$26,981 | -$28,829 | -$26,640 |